Development of a psma-targeted small-molecule drug conjugate for prostate cancer
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA221511
- Recipient
-
Cancer Targeted Technology LLC UEI G2CENLL6M648
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Woodinville, WA, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R43CA221511?
R43CA221511 was awarded to Cancer Targeted Technology LLC by National Cancer Institute (National Institutes of Health) on September 19, 2018.
How much is award R43CA221511 worth?
$300,000 has been obligated on R43CA221511.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award